Integrating multi-modal transcriptomics identifies cellular subtypes with distinct roles in PDAC progression

Abstract

BackgroundPancreatic ductal adenocarcinoma (PDAC) features a complex tumor microenvironment (TME) that significantly influences patient outcomes. Understanding the TMEs cellular composition and interactions is crucial for identifying therapeutic targets to improve treatment. MethodsWe performed an integrative analysis combining 88 single-cell RNA sequencing (scRNA-seq) samples with 187,520 cells, 20 Visium spatial transcriptomics (ST-seq) samples with 67,933 spots, and 1383 bulk RNA-seq samples and 2 Xenium high-resolution ST-seq samples with 307,679 cells, to delineate and characterize distinct subpopulations of fibroblasts, macrophages, T/NK cells, and B/plasma cells within the PDAC microenvironment. Correlations among major cell types across 12 PDAC datasets were assessed through gene set variation analysis (GSVA). Kaplan-Meier survival analysis was used to evaluate the prognostic significance of cell subtypes. Furthermore, multiplex immunohistochemistry (mIHC) and the Xenium platform was utilized to validate cellular interactions in human PDAC tissues at both protein and RNA levels. ResultsSix fibroblast subtypes and eight macrophage/monocyte subtypes were identified. POSTN high fibroblasts and SPP1 high macrophages highly infiltrated tumor tissues and were associated with poor prognosis. Most immune cell subtypes mediate adverse prognoses, except for CCL4 high CD8+ T EFF cells and IGHG1 high plasma cells, which are linked to favorable outcomes. ST-seq revealed spatial colocalization of POSTN high Fibro and SPP1 high Macro cells, as well as CCL4 high CD8+ T EFF and IGHG1 high plasma cells. These findings were corroborated by mIHC and validated using Xenium spatial transcriptomics with single-cell resolution, which confirmed the expression and spatial proximity of these markers at both the gene and protein levels. ConclusionThis integrative analysis of the PDAC TME underscores the prognostic importance of POSTN high fibroblasts and SPP1 high macrophages, while also highlighting the protective roles of CCL4 high CD8+ T EFF cells and IGHG1 high plasma cells. These insights could improve PDAC treatment strategies.